TABLE 1.
ADHERENCE TO EVIDENCE-BASED GUIDELINES: PAIN ASSESSMENT
| Adherence | |||
|---|---|---|---|
| Assessment Quality Indicator | % | n | Total Chartsa |
| Chronic pain assessed at least once per week. | 32 | 90 | 285 |
|
Pain location assessed two or more times in the past 30 days. |
35 | 94 | 269 |
|
Intensity of moderate to severe pain assessed weekly; no to mild pain assessed two times per month. |
25 | 70 | 285 |
|
Pain character assessed at least once in the past 30 days. |
7 | 19 | 257 |
|
Pain pattern assessed two or more times in the past 30 days. |
<1 | 1 | 265 |
|
Effect of pain on function/quality of life assessed two or more times in the past 30 days. |
3 | 9 | 270 |
|
Effectiveness of overall pain treatment assessed in the past 30 days. |
20 | 57 | 285 |
|
Reassessment following initiation or titration up of a drug within expected time frame. |
55 | 35 | 64 |
|
Side effects assessed: new medications, within first week and weekly; previous medications, once per month. |
18 | 42 | 236 |
Note. Percentages represent adherence to evidence-based guidelines at the highest level.
a
Denominator for each item excludes all charts for which the item was marked as not applicable.